- Tytuł:
- Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
- Autorzy:
- Źródło:
- Annals of surgery [Ann Surg] 2021 Dec 01; Vol. 274 (6), pp. e689-e690.
- Typ publikacji:
- Letter; Comment
- Język:
- English
- Imprint Name(s):
- Original Publication: Philadelphia, PA : Lippincott Williams & Wilkins
- MeSH Terms:
-
C-Reactive Protein*
Colorectal Neoplasms*/surgery
Biomarkers ; Humans ; Lymphocytes ; Prognosis - References:
-
Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg 2019; [Epub ahead of print].
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539–545.
Guner A, Kim SY, Yu JE, et al. Parameters for predicting surgical outcomes for gastric cancer patients: simple is better than complex. Ann Surg Oncol 2018; 25:3239–3247.
Karagkounis G, Thai L, Mace AG, et al. Prognostic implications of pathological response to neoadjuvant chemoradiation in pathologic stage III rectal cancer. Ann Surg 2019; 269:1117–1123.
Tie J, Cohen JD, Wang Y, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol 2019; [Epub ahead of print] Erratum in: JAMA Oncol . 2019;5:1811. - Substance Nomenclature:
-
0 (Biomarkers)
9007-41-4 (C-Reactive Protein) - Entry Date(s):
- Date Created: 20200609 Date Completed: 20211214 Latest Revision: 20220720
- Update Code:
- 20240104
- DOI:
- 10.1097/SLA.0000000000003856
- PMID:
- 32511130
- Opinia redakcyjna
Menu główne
Wyszukiwarka
Treść główna
